Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii.

Nagarajan D, Roy N, Kulkarni O, Nanajkar N, Datey A, Ravichandran S, Thakur C, T S, Aprameya IV, Sarma SP, Chakravortty D, Chandra N.

Sci Adv. 2019 Jul 24;5(7):eaax1946. doi: 10.1126/sciadv.aax1946. eCollection 2019 Jul.

2.

Synthesis and Evaluation of Novel Pyrazole Ethandiamide Compounds as Inhibitors of Human THP-1 Monocytic Cell Neurotoxicity.

McKenzie JA, Barghash RF, Alsaggaf AT, Kulkarni O, Boudreau K, Menard F, Neeland EG, Klegeris A.

Cells. 2019 Jun 29;8(7). pii: E655. doi: 10.3390/cells8070655.

3.

l-Proline-based-cyclic dipeptides from Pseudomonas sp. (ABS-36) inhibit pro-inflammatory cytokines and alleviate crystal-induced renal injury in mice.

Begum Ahil S, Hira K, Shaik AB, Pal PP, Kulkarni OP, Araya H, Fujimoto Y.

Int Immunopharmacol. 2019 Aug;73:395-404. doi: 10.1016/j.intimp.2019.05.044. Epub 2019 May 28.

PMID:
31151077
4.

Using high-throughput sequencing for investigating intra-host hepatitis C evolution over long retrospective periods.

Caporossi A, Kulkarni O, Blum M, Leroy V, Morand P, Larrat S, François O.

Infect Genet Evol. 2019 Jan;67:136-144. doi: 10.1016/j.meegid.2018.11.004. Epub 2018 Nov 3.

PMID:
30395998
5.

A general approach to intermolecular carbonylation of arene C-H bonds to ketones through catalytic aroyl triflate formation.

Garrison Kinney R, Tjutrins J, Torres GM, Liu NJ, Kulkarni O, Arndtsen BA.

Nat Chem. 2018 Feb;10(2):193-199. doi: 10.1038/nchem.2903. Epub 2017 Dec 11.

PMID:
29359763
6.

Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.

Nagarajan D, Nagarajan T, Roy N, Kulkarni O, Ravichandran S, Mishra M, Chakravortty D, Chandra N.

J Biol Chem. 2018 Mar 9;293(10):3492-3509. doi: 10.1074/jbc.M117.805499. Epub 2017 Dec 19.

7.

A Case of 3-month-old Neglected Elbow Dislocation Managed by Open Reduction and Cruciate Ligament Reconstruction Using Tendon Graft.

Pundkar GN, Sonar SB, Kulkarni OP.

J Orthop Case Rep. 2017 Jul-Aug;7(4):58-60. doi: 10.13107/jocr.2250-0685.852.

8.

Reprint of "Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis".

Devarapu SK, Kumar Vr S, Rupanagudi KV, Kulkarni OP, Eulberg D, Klussmann S, Anders HJ.

Clin Immunol. 2017 Dec;185:119-127. doi: 10.1016/j.clim.2017.10.011. Epub 2017 Oct 28.

PMID:
29111236
9.

Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients.

Epaulard O, Signori-Schmuck A, Larrat S, Kulkarni O, Blum MG, Fusillier K, Blanc M, Leclercq P, François O, Morand P.

J Clin Virol. 2017 Oct;95:13-19. doi: 10.1016/j.jcv.2017.07.013. Epub 2017 Jul 25.

PMID:
28830014
10.

Hepatoprotective Activity of Satwa, an Ayurvedic Formulation, Against Alcohol-induced Liver Injury in Rats.

Chavan T, Ghadge A, Karandikar M, Pandit V, Ranjekar P, Kulkarni O, Kuvalekar A, Mantri N.

Altern Ther Health Med. 2017 Jul;23(4):34-40.

PMID:
28646813
11.

Cellular and Molecular Mechanisms of Autoimmunity and Lupus Nephritis.

Devarapu SK, Lorenz G, Kulkarni OP, Anders HJ, Mulay SR.

Int Rev Cell Mol Biol. 2017;332:43-154. doi: 10.1016/bs.ircmb.2016.12.001. Epub 2017 Feb 4. Review.

PMID:
28526137
12.

Zein Microneedles for Transcutaneous Vaccine Delivery: Fabrication, Characterization, and in Vivo Evaluation Using Ovalbumin as the Model Antigen.

Bhatnagar S, Chawla SR, Kulkarni OP, Venuganti VVK.

ACS Omega. 2017 Apr 30;2(4):1321-1332. doi: 10.1021/acsomega.7b00343. Epub 2017 Apr 6.

13.

Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles.

Labala S, Jose A, Chawla SR, Khan MS, Bhatnagar S, Kulkarni OP, Venuganti VVK.

Int J Pharm. 2017 Jun 20;525(2):407-417. doi: 10.1016/j.ijpharm.2017.03.087. Epub 2017 Apr 1.

PMID:
28373100
14.

The innate immune system in human systemic lupus erythematosus.

Weidenbusch M, Kulkarni OP, Anders HJ.

Clin Sci (Lond). 2017 Apr 25;131(8):625-634. doi: 10.1042/CS20160415. Review.

PMID:
28351959
15.

Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center.

Graebner AK, Tarsy D, Shih LC, Vanderhorst V, Kulkarni O, Kaplan S, Simon DK.

Neurodegener Dis. 2017;17(1):38-43. Epub 2016 Sep 10.

PMID:
27614874
16.

The Immune System in Tissue Environments Regaining Homeostasis after Injury: Is "Inflammation" Always Inflammation?

Kulkarni OP, Lichtnekert J, Anders HJ, Mulay SR.

Mediators Inflamm. 2016;2016:2856213. doi: 10.1155/2016/2856213. Epub 2016 Aug 11. Review.

17.

Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.

Devarapu SK, Kumar Vr S, Rupanagudi KV, Kulkarni OP, Eulberg D, Klussmann S, Anders HJ.

Clin Immunol. 2016 Aug;169:139-147. doi: 10.1016/j.clim.2016.07.003. Epub 2016 Jul 5.

PMID:
27392463
18.

Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation.

Andersen K, Kesper MS, Marschner JA, Konrad L, Ryu M, Kumar Vr S, Kulkarni OP, Mulay SR, Romoli S, Demleitner J, Schiller P, Dietrich A, Müller S, Gross O, Ruscheweyh HJ, Huson DH, Stecher B, Anders HJ.

J Am Soc Nephrol. 2017 Jan;28(1):76-83. doi: 10.1681/ASN.2015111285. Epub 2016 May 5.

19.

Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis.

Mulay SR, Desai J, Kumar SV, Eberhard JN, Thomasova D, Romoli S, Grigorescu M, Kulkarni OP, Popper B, Vielhauer V, Zuchtriegel G, Reichel C, Bräsen JH, Romagnani P, Bilyy R, Munoz LE, Herrmann M, Liapis H, Krautwald S, Linkermann A, Anders HJ.

Nat Commun. 2016 Jan 28;7:10274. doi: 10.1038/ncomms10274.

20.

Anti-fatigue effect of Amarkand on endurance exercise capacity in rats.

Narkhede AN, Jagtap SD, Nirmal PS, Giramkar SA, Nagarkar BE, Kulkarni OP, Harsulkar AM.

BMC Complement Altern Med. 2016 Jan 22;16:23. doi: 10.1186/s12906-016-0995-2.

21.

Association of Fasting Plasma Glucose and Serum Lipids in Type 2 Diabetics.

Khadke S, Harke S, Ghadge A, Kulkarni O, Bhalerao S, Diwan A, Pankaj M, Kuvalekar A.

Indian J Pharm Sci. 2015 Sep-Oct;77(5):630-4.

22.

One-Pot Cannizzaro Cascade Synthesis of ortho-Fused Cycloocta-2,5-dien-1-ones from 2-Bromo(hetero)aryl Aldehydes.

Burroughs L, Eccleshare L, Ritchie J, Kulkarni O, Lygo B, Woodward S, Lewis W.

Angew Chem Int Ed Engl. 2015 Sep 1;54(36):10648-51. doi: 10.1002/anie.201505347. Epub 2015 Jul 29.

23.

Effects of commonly used antidiabetic drugs on antioxidant enzymes and liver function test markers in type 2 diabetes mellitus subjects - pilot study.

Ghadge A, Harke S, Khadke S, Diwan A, Pankaj M, Kulkarni O, Ranjekar P, Harsulkar A, Kuvalekar AA.

Exp Clin Endocrinol Diabetes. 2015 Sep;123(8):500-7. doi: 10.1055/s-0035-1554654. Epub 2015 Jul 27.

PMID:
26216367
24.

Neutrophil Extracellular Trap-Related Extracellular Histones Cause Vascular Necrosis in Severe GN.

Kumar SV, Kulkarni OP, Mulay SR, Darisipudi MN, Romoli S, Thomasova D, Scherbaum CR, Hohenstein B, Hugo C, Müller S, Liapis H, Anders HJ.

J Am Soc Nephrol. 2015 Oct;26(10):2399-413. doi: 10.1681/ASN.2014070673. Epub 2015 Feb 2.

25.

Circulatory adipocytokines and lipid profile variations in type-2 diabetic subjects: desirable side-effects of antidiabetic drugs.

Ghadge AA, Harke SM, Khadke SP, Diwan AG, Pankaj M, Kulkarni OP, Ranjekar PK, Kuvalekar AA.

Diabetes Metab Syndr. 2014 Oct-Dec;8(4):230-2. doi: 10.1016/j.dsx.2014.09.010. Epub 2014 Oct 13.

PMID:
25450822
26.

Ultradeep pyrosequencing of NS3 to predict response to triple therapy with protease inhibitors in previously treated chronic hepatitis C patients.

Larrat S, Kulkarni O, Claude JB, Beugnot R, Blum MG, Fusillier K, Lupo J, Tremeaux P, Plages A, Marlu A, Duborjal H, Signori-Schmuck A, Francois O, Zarski JP, Morand P, Leroy V.

J Clin Microbiol. 2015 Feb;53(2):389-97. doi: 10.1128/JCM.02547-14. Epub 2014 Nov 19.

27.
28.

NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-β receptor signalling.

Lech M, Lorenz G, Kulkarni OP, Grosser MO, Stigrot N, Darisipudi MN, Günthner R, Wintergerst MW, Anz D, Susanti HE, Anders HJ.

Ann Rheum Dis. 2015 Dec;74(12):2224-35. doi: 10.1136/annrheumdis-2014-205496. Epub 2014 Aug 18.

PMID:
25135254
29.

Effect of combination treatment of S-amlodipine with peroxisome proliferator-activated receptor agonists on metabolic and cardiovascular parameters in Zucker fa/fa rats.

Singh B, Sangle GV, Murugan J, Umrani R, Roy S, Kulkarni O, Semwal A, Unnikrishnan M, Jain M.

Diabetol Metab Syndr. 2014 Mar 28;6(1):45. doi: 10.1186/1758-5996-6-45.

30.

Toll-like receptor 4-induced IL-22 accelerates kidney regeneration.

Kulkarni OP, Hartter I, Mulay SR, Hagemann J, Darisipudi MN, Kumar Vr S, Romoli S, Thomasova D, Ryu M, Kobold S, Anders HJ.

J Am Soc Nephrol. 2014 May;25(5):978-89. doi: 10.1681/ASN.2013050528. Epub 2014 Jan 23.

31.

Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming.

Rupanagudi KV, Kulkarni OP, Lichtnekert J, Darisipudi MN, Mulay SR, Schott B, Gruner S, Haap W, Hartmann G, Anders HJ.

Ann Rheum Dis. 2015 Feb;74(2):452-63. doi: 10.1136/annrheumdis-2013-203717. Epub 2013 Dec 3.

PMID:
24300027
32.

Influence of six medicinal herbs on collagenase-induced osteoarthritis in rats.

Nirmal P, Koppikar S, Bhondave P, Narkhede A, Nagarkar B, Kulkarni V, Wagh N, Kulkarni O, Harsulkar A, Jagtap S.

Am J Chin Med. 2013;41(6):1407-25. doi: 10.1142/S0192415X13500948.

PMID:
24228609
33.

Podocyte loss involves MDM2-driven mitotic catastrophe.

Mulay SR, Thomasova D, Ryu M, Kulkarni OP, Migliorini A, Bruns H, Gröbmayr R, Lazzeri E, Lasagni L, Liapis H, Romagnani P, Anders HJ.

J Pathol. 2013 Jul;230(3):322-35. doi: 10.1002/path.4193.

PMID:
23749457
34.

The antiviral cytokines IFN-α and IFN-β modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration.

Migliorini A, Angelotti ML, Mulay SR, Kulkarni OO, Demleitner J, Dietrich A, Sagrinati C, Ballerini L, Peired A, Shankland SJ, Liapis H, Romagnani P, Anders HJ.

Am J Pathol. 2013 Aug;183(2):431-40. doi: 10.1016/j.ajpath.2013.04.017. Epub 2013 Jun 5.

PMID:
23747509
35.

Sternutatory reflex induced by periocular needle insertion in patients receiving chronic botulinum toxin injections.

Kulkarni OC, Cox CA, Hedges TR 3rd, Tarsy D.

Parkinsonism Relat Disord. 2013 Aug;19(8):770-1. doi: 10.1016/j.parkreldis.2013.04.014. Epub 2013 May 13. No abstract available.

PMID:
23680422
36.

The "floating door sign" in Parkinson's disease.

Kulkarni O, Lafaver K, Tarsy D.

Parkinsonism Relat Disord. 2013 Sep;19(9):825-6. doi: 10.1016/j.parkreldis.2013.04.013. Epub 2013 May 7.

PMID:
23660546
37.

Re:imagine: a report on the UHC Annual Conference 2012.

White C, Groenewold JJ, Lofgren RP, Meurer SJ, Johnson S, Rogers M, Campbell C, Barbour H, Brazile D, Ondrasik J, Tesmer A, DeBehnke D, Kulkarni OP, van der Geest K, Hart K, Hubenette A, Mass S, Samuels B, Murray J, Carr L, Smith J, Sweeney B, Johnston ML, Angeles PD, Meaney N, Best A, Adams-Campbell H, Hepburn-Smith M, Swarthout MD, Efird L, Nesbit TW, Cawley PJ, Sachs BL, Rees CE, Berman B, Halperin J, Amalfitano C, Anghel S, Luka N, Maund C, Postighone R, Ruggiero C, Belisle C, Stashek C, Dellit TH, Schreuder AB, Leverentz DM, Simon M, Mohan H, Graff AE, Radford MJ, Rivera ML, Bennan J, Hoiting T, Hayes BD, Feemster AA, Benedetti TJ, Walker S, Truwit JD, Enfield KB, Li J, William BJ, Grover-Patrick T, Kay NK, Young JS, Adrian B, Ringel SP, Cole B, Scanlon K, Schwarz R, Pontieri-Lewis V, Ryan J, Martinson W, Eckel SF, Granko RP, Savage S, Crisp B, Smith E, Daniels R, Brennan P, Rich V, Doyle J, May L, Wagner M, Collins B, Lewin G, Ambookan M, Vertichio R, Joseph A, Jackson GF, Maher M, Sabel A, Valdez C, Brown B, Moldenhauer K, Chou J, MacKenzie TD, Lovett PB, Davis-Moon L, Mathew RG, Randolph FT.

Am J Med Qual. 2013 Mar-Apr;28(1 Suppl):3S-28S. doi: 10.1177/1062860612470786. No abstract available.

PMID:
23462139
38.

Thalamic and subthalamic deep brain stimulation for parkinsonian tremor: are two circuits involved?

Kulkarni O, Lafaver K, Papavassiliou E, Tarsy D, Shih LC.

Mov Disord. 2013 Apr;28(4):554-5. doi: 10.1002/mds.25299. Epub 2013 Feb 6. No abstract available.

PMID:
23389961
39.

Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury.

Lech M, Römmele C, Gröbmayr R, Eka Susanti H, Kulkarni OP, Wang S, Gröne HJ, Uhl B, Reichel C, Krombach F, Garlanda C, Mantovani A, Anders HJ.

Kidney Int. 2013 Apr;83(4):647-61. doi: 10.1038/ki.2012.463. Epub 2013 Jan 16.

40.

Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion.

Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, Muruve D, Shi Y, Munro F, Liapis H, Anders HJ.

J Clin Invest. 2013 Jan;123(1):236-46. doi: 10.1172/JCI63679. Epub 2012 Dec 10.

41.

Lupus nephritis. How latest insights into its pathogenesis promote novel therapies.

Kulkarni OP, Anders HJ.

Curr Opin Rheumatol. 2012 Sep;24(5):457-65. doi: 10.1097/BOR.0b013e328354c877. Review.

PMID:
22810362
42.

Evaluation of comparative free-radical quenching potential of Brahmi (Bacopa monnieri) and Mandookparni (Centella asiatica).

Mukherjee S, Dugad S, Bhandare R, Pawar N, Jagtap S, Pawar PK, Kulkarni O.

Ayu. 2011 Apr;32(2):258-64. doi: 10.4103/0974-8520.92549.

43.

Anti-GBM glomerulonephritis involves IL-1 but is independent of NLRP3/ASC inflammasome-mediated activation of caspase-1.

Lichtnekert J, Kulkarni OP, Mulay SR, Rupanagudi KV, Ryu M, Allam R, Vielhauer V, Muruve D, Lindenmeyer MT, Cohen CD, Anders HJ.

PLoS One. 2011;6(10):e26778. doi: 10.1371/journal.pone.0026778. Epub 2011 Oct 27.

44.

Recombinant chaperonin 10 suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice.

Kulkarni OP, Ryu M, Kantner C, Sárdy M, Naylor D, Lambert D, Brown R, Anders HJ.

Nephrol Dial Transplant. 2012 Apr;27(4):1358-67. doi: 10.1093/ndt/gfr544. Epub 2011 Oct 10.

PMID:
21987536
45.

Mdm2 promotes systemic lupus erythematosus and lupus nephritis.

Allam R, Sayyed SG, Kulkarni OP, Lichtnekert J, Anders HJ.

J Am Soc Nephrol. 2011 Nov;22(11):2016-27. doi: 10.1681/ASN.2011010045. Epub 2011 Sep 23.

46.

Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.

Lech M, Kantner C, Kulkarni OP, Ryu M, Vlasova E, Heesemann J, Anz D, Endres S, Kobayashi KS, Flavell RA, Martin J, Anders HJ.

Ann Rheum Dis. 2011 Dec;70(12):2207-17. doi: 10.1136/ard.2011.155515. Epub 2011 Aug 29.

PMID:
21875872
47.

Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.

Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.

J Immunol. 2011 Sep 15;187(6):3413-21. doi: 10.4049/jimmunol.1101125. Epub 2011 Aug 17.

48.

IRF4 deficiency abrogates lupus nephritis despite enhancing systemic cytokine production.

Lech M, Weidenbusch M, Kulkarni OP, Ryu M, Darisipudi MN, Susanti HE, Mittruecker HW, Mak TW, Anders HJ.

J Am Soc Nephrol. 2011 Aug;22(8):1443-52. doi: 10.1681/ASN.2010121260. Epub 2011 Jul 8.

49.

Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease.

Darisipudi MN, Kulkarni OP, Sayyed SG, Ryu M, Migliorini A, Sagrinati C, Parente E, Vater A, Eulberg D, Klussmann S, Romagnani P, Anders HJ.

Am J Pathol. 2011 Jul;179(1):116-24. doi: 10.1016/j.ajpath.2011.03.004. Epub 2011 Apr 30.

50.

Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus.

Lech M, Römmele C, Kulkarni OP, Susanti HE, Migliorini A, Garlanda C, Mantovani A, Anders HJ.

PLoS One. 2011;6(5):e20118. doi: 10.1371/journal.pone.0020118. Epub 2011 May 27.

Supplemental Content

Loading ...
Support Center